Guermazi, Dorra
Arvanitis, Panos
Vieira, Kendra
Warner, Jeremy L.
Farmakiotis, Dimitrios
Article History
Received: 18 January 2024
Accepted: 4 July 2024
First Online: 9 July 2024
Declarations
:
: The study was approved by the Lifespan Institutional Review Board (IRB). The study was conducted in accordance with the Declaration of Helsinki.
: The study was approved by the Lifespan Institutional Review Board (IRB) with a waiver of informed consent given its retrospective design and de-identified data.
: All authors agreed to the publication of the manuscript.
: DF has received research support from Viracor, Astellas, and Merck and consultant fee from Viracor. All other authors have nothing to disclose.